Medicine and Dentistry
Oropharynx Squamous Cell Carcinoma
75%
Wart Virus
73%
Radiation Therapy
72%
Neoplasm
54%
P16
40%
Oropharynx Carcinoma
40%
Overall Survival
39%
Neck
36%
Recurrent Disease
26%
Head and Neck Squamous Cell Carcinoma
26%
Diseases
25%
Intensity Modulated Radiation Therapy
25%
Head and Neck Cancer
24%
Hazard Ratio
21%
Squamous Cell Carcinoma
19%
Cisplatin
18%
Disease Free Survival
17%
Disease Specific Survival
16%
Malignant Neoplasm
15%
Oncology
13%
Distant Metastasis
12%
Induction Chemotherapy
11%
Biological Marker
10%
Contouring
10%
Adjuvant Therapy
10%
microRNA
10%
Cetuximab
9%
Surgery
9%
Lymph Node
8%
Cancer
8%
Oropharynx
8%
Progression Free Survival
8%
Merkel Cell Carcinoma
8%
Paclitaxel
8%
Computer Assisted Tomography
8%
Treatment Planning
7%
Metastatic Carcinoma
7%
Phase II Trials
7%
In Situ Hybridization
7%
Tissue Microarray
6%
Quality of Life
6%
Primary Tumor
6%
Positron Emission Tomography-Computed Tomography
6%
Neck Dissection
6%
Cancer of Unknown Primary Origin
6%
Chemoradiotherapy
6%
Clinical Trial
6%
Cancer Therapy
5%
Oral Cavity
5%
Positron Emission Tomography
5%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
High-risk Human Papillomavirus (HR-HPV)
77%
Radiation Therapy
48%
Overall Survival
41%
Tumor
36%
Head-and-neck Cancer
35%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
33%
Head-and-neck
30%
P16-positive
23%
Locally Advanced
22%
Hazard Ratio
21%
Cisplatin
21%
Confidence Interval
21%
Disease-specific Survival
18%
Radiotherapy
18%
Disease-free Survival
17%
Nasopharyngeal Carcinoma
16%
Distant Metastasis
14%
Phase II Trial
14%
Intensity-modulated Radiation Therapy
14%
Induction Chemotherapy
13%
Adjuvant Therapy
12%
Cetuximab
11%
Surgically Treated
11%
Squamous Cell Carcinoma of Head
11%
Nab-paclitaxel
10%
Recurrent Disease
10%
Tumor Delineation
9%
Neck Dissection
9%
Progression-free Survival
9%
Intraoperative Radiation Therapy
9%
Radiation Therapy Oncology Group
9%
Transoral Surgery
9%
NRG Oncology
8%
Positron Emission Tomography-computed Tomography (PET-CT)
8%
Gene Signature
8%
Merkel Cell Carcinoma
8%
Computed Tomography
8%
Non-small Cell Lung Cancer (NSCLC)
8%
Concurrent Radiation
7%
Cancer Outcomes
7%
Tissue Microarray
7%
MicroRNA
7%
Intensity-modulated Radiotherapy
7%
Locoregional Recurrence
7%
Squamous Cell Carcinoma (SqCC)
6%
Patient Outcomes
6%
Treatment Outcome
6%
Lung
6%
Tumor Volume
6%